Ugel et al. found that a tumor is able to induce CCR2+ inflammatory monocytes, which are characterized by myeloid progenitor cells, to expand in the marginal zone of the spleen, and that these cells cross‐present tumor antigen memory CD 8+ T cells to trigger immune tolerance.29 This evidence concerns the gene CCR2 and neoplasm.